LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 90

Search options

  1. Article ; Online: Very Early Diagnosis of Systemic Sclerosis in Clinical Practice - Case Report and Review of the Literature.

    Marković, Ivan / Posavec, Anja Ljilja / Morović-Vergles, Jadranka / Mitrović, Joško

    Acta dermatovenerologica Croatica : ADC

    2023  Volume 30, Issue 4, Page(s) 251–255

    Abstract: Systemic sclerosis (SSc) is a systemic autoimmune disease characterised by generalized microangiopathy and fibrosis of skin and internal organs. The 2013 American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) criteria have ... ...

    Abstract Systemic sclerosis (SSc) is a systemic autoimmune disease characterised by generalized microangiopathy and fibrosis of skin and internal organs. The 2013 American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) criteria have contributed considerably to classifying patients with SSc in earlier stages, but they still lack sensitivity for a very early stage of the disease. Criteria for a very early diagnosis of SSc (VEDOSS) have been proposed by EULAR Scleroderma Trial and Research group (EUSTAR) which include three red flags: Raynaud's phenomenon, puffy fingers and antinuclear antibody positivity, plus SSc specific antibodies positivity and/or abnormal nailfold capillaroscopy. We report a case of a 54-year-old female patient with 6-week history of puffy fingers, Raynaud phenomenon and positive antinuclear antibodies. Further workup revealed early pathologic capillary pattern by nailfold capillaroscopy and positive anticentromere antibodies. Screening for internal organ involvement detected no heart, lung, or upper gastrointestinal tract involvement. The patient was started on pentoxifylline with further follow-up. The aim of the implementation of VEDOSS criteria is to diagnose SSc at the earliest possible stage, so that subclinical internal organ involvement could be detected and appropriate treatment started at a potentially reversible stage.
    MeSH term(s) Female ; Humans ; Middle Aged ; Scleroderma, Systemic/diagnosis ; Rheumatology ; Early Diagnosis ; Raynaud Disease/diagnosis ; Raynaud Disease/etiology ; Scleroderma, Localized
    Language English
    Publishing date 2023-03-08
    Publishing country Croatia
    Document type Review ; Case Reports
    ZDB-ID 1180727-1
    ISSN 1847-6538 ; 1330-027X
    ISSN (online) 1847-6538
    ISSN 1330-027X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Alpha-gal syndrome-Food or drug allergy: A case report.

    Božan, Marina / Vukičević Lazarević, Vesna / Marković, Ivan / Morović-Vergles, Jadranka / Mitrović, Joško

    Clinical case reports

    2023  Volume 11, Issue 9, Page(s) e7830

    Abstract: Alpha-gal syndrome is an immunoglobulin E-mediated hypersensitivity characterized by delayed allergic reactions to ingested products containing alpha-gal carbohydrate. We present a patient with recurrent urticaria and suspected repaglinide ... ...

    Abstract Alpha-gal syndrome is an immunoglobulin E-mediated hypersensitivity characterized by delayed allergic reactions to ingested products containing alpha-gal carbohydrate. We present a patient with recurrent urticaria and suspected repaglinide hypersensitivity, who was eventually diagnosed with alpha-gal syndrome, wanting to emphasize possible drug allergy misdiagnosis and required caution with the medication choice.
    Language English
    Publishing date 2023-08-24
    Publishing country England
    Document type Case Reports
    ZDB-ID 2740234-4
    ISSN 2050-0904
    ISSN 2050-0904
    DOI 10.1002/ccr3.7830
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Komorbiditet u bolesnika s reumatoidnim artritisom.

    Pukšić, Silva / Morović-Vergles, Jadranka

    Reumatizam

    2014  Volume 61, Issue 2, Page(s) 31–36

    Abstract: Comorbidity in rheumatoid arthritis (RA) patients significantly impairs and limits management of primary disease, decreases general quality of life, and worsens outcomes. Cardiovascular comorbidity is the leading cause of excess mortality in RA patients, ...

    Title translation Comorbidities in patients with rheumatoid arthritis.
    Abstract Comorbidity in rheumatoid arthritis (RA) patients significantly impairs and limits management of primary disease, decreases general quality of life, and worsens outcomes. Cardiovascular comorbidity is the leading cause of excess mortality in RA patients, which is up to two times higher compared to the general population. Infections, pulmonary disease and malignant diseases also contribute to excess mortality, while fatigue, depression and osteoporosis are related to decreased quality of life. Adequate management of RA patients should therefore, besides tight control of disease activity, also include comorbidity screening and management. This approach should improve both RA and comorbidity related outcomes.
    Language Croatian
    Publishing date 2014
    Publishing country Croatia
    Document type English Abstract ; Journal Article
    ZDB-ID 604372-0
    ISSN 0374-1338
    ISSN 0374-1338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Komorbiditet u bolesnika s reumatoidnim artritisom.

    Pukšić, Silva / Morović-Vergles, Jadranka

    Reumatizam

    2014  Volume 61, Issue 2, Page(s) 31–36

    Abstract: Comorbidity in rheumatoid arthritis (RA) patients significantly impairs and limits management of primary disease, decreases general quality of life, and worsens outcomes. Cardiovascular comorbidity is the leading cause of excess mortality in RA patients, ...

    Title translation Comorbidities in patients with rheumatoid arthritis.
    Abstract Comorbidity in rheumatoid arthritis (RA) patients significantly impairs and limits management of primary disease, decreases general quality of life, and worsens outcomes. Cardiovascular comorbidity is the leading cause of excess mortality in RA patients, which is up to two times higher compared to the general population. Infections, pulmonary disease and malignant diseases also contribute to excess mortality, while fatigue, depression and osteoporosis are related to decreased quality of life. Adequate management of RA patients should therefore, besides tight control of disease activity, also include comorbidity screening and management. This approach should improve both RA and comorbidity related outcomes.
    MeSH term(s) Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/mortality ; Cardiovascular Diseases/complications ; Humans ; Neoplasms/complications ; Osteoporosis/complications ; Quality of Life
    Language Croatian
    Publishing date 2014
    Publishing country Croatia
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 604372-0
    ISSN 0374-1338
    ISSN 0374-1338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: "Rituximab: A Safe Treatment in a Patient With Refractory Felty Syndrome and Recurrent Infections".

    Pukšić, Silva / Mitrović, Joško / Morović-Vergles, Jadranka

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

    2017  Volume 23, Issue 1, Page(s) 70–71

    MeSH term(s) Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/adverse effects ; Drug Monitoring/methods ; Drug Resistance ; Felty Syndrome/blood ; Felty Syndrome/complications ; Felty Syndrome/diagnosis ; Felty Syndrome/drug therapy ; Female ; Humans ; Infection/diagnosis ; Infection/etiology ; Infection/physiopathology ; Leukocyte Count/methods ; Middle Aged ; Recurrence ; Rituximab/administration & dosage ; Rituximab/adverse effects ; Treatment Outcome ; Tumor Necrosis Factor-alpha/analysis ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
    Chemical Substances Antirheumatic Agents ; Tumor Necrosis Factor-alpha ; Rituximab (4F4X42SYQ6)
    Language English
    Publishing date 2017-01
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 1283266-2
    ISSN 1536-7355 ; 1076-1608
    ISSN (online) 1536-7355
    ISSN 1076-1608
    DOI 10.1097/RHU.0000000000000440
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Kardiovaskularne bolesti i reumatoidni artritis.

    Morović-Vergles, Jadranka

    Reumatizam

    2010  Volume 57, Issue 2, Page(s) 11–15

    Abstract: Morbidity and mortality rates are higher in rheumatoid arthritis (RA) patients than in the general population. RA is associated with an increased risk of cardiovascular disease. All of the cardiac structures can be affected during the course of RA. ... ...

    Title translation Cardiovascular diseases and rheumatoid arthritis.
    Abstract Morbidity and mortality rates are higher in rheumatoid arthritis (RA) patients than in the general population. RA is associated with an increased risk of cardiovascular disease. All of the cardiac structures can be affected during the course of RA. Rheumatoid arthritis, per se, is a cardiovascular (CV) risk factor as arterial hypertension, dyslipidemia and diabetes etc. Although the increased CV risk is acknowledged, limited attention is paid to detecting and managing CV comorbid conditions. Early identification, adequate CV risk management and ongoing monitoring of risk factors are mandatory to reduce the CV risk. Also, adequate control of arthritis disease activity is necessary to lower CV risk.
    MeSH term(s) Arthritis, Rheumatoid/complications ; Cardiovascular Diseases/etiology ; Humans ; Risk Factors
    Language Croatian
    Publishing date 2010
    Publishing country Croatia
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 604372-0
    ISSN 0374-1338
    ISSN 0374-1338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Sigurnost primjene rituximaba u bolesnika s reumatoidnim artritisom.

    Morović-Vergles, Jadranka

    Reumatizam

    2010  Volume 57, Issue 2, Page(s) 158–160

    Abstract: RA is a chronic disease and long-term use of treatments that target TNF or B cells will be required for continued disease control. One approach to targeting B cells in RA is the use ofrituximab. It is a genetically engineered chimeric monoclonal antibody ...

    Title translation Safety of rituximab in patients with rheumatoid arthritis.
    Abstract RA is a chronic disease and long-term use of treatments that target TNF or B cells will be required for continued disease control. One approach to targeting B cells in RA is the use ofrituximab. It is a genetically engineered chimeric monoclonal antibody that selectively depletes peripheral B lymphocytes by binding CD20 on the cell surface. Long-term safety data show that rituximab treatment is associated with rates of infections and serious infections that remain stable over multiple treatment courses. Also, is associated with rates of malignancy consistent with data from the general RA population and is not associated with an increase in the rate of serious infections in patients who receive subsequent biologic treatment. In conclusion, rituximab is generally safe and well tolerated.
    MeSH term(s) Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/therapeutic use ; Arthritis, Rheumatoid/drug therapy ; Humans ; Rituximab
    Chemical Substances Antibodies, Monoclonal, Murine-Derived ; Antirheumatic Agents ; Rituximab (4F4X42SYQ6)
    Language Croatian
    Publishing date 2010
    Publishing country Croatia
    Document type English Abstract ; Journal Article
    ZDB-ID 604372-0
    ISSN 0374-1338
    ISSN 0374-1338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The effect of smoking on disease activity in rheumatoid arthritis - our experience.

    Gudelj Gračanin, Ana / Marković, Ivan / Golob, Majda / Lucijanić, Marko / Valetić, Ana Marija / Morović-Vergles, Jadranka

    Acta clinica Croatica

    2021  Volume 59, Issue 2, Page(s) 312–317

    Abstract: The aim of this study was to investigate the association of smoking with disease activity, seropositivity, age and gender in patients with rheumatoid arthritis. We included 89 rheumatoid arthritis patients. All patients fulfilled the 2010 American ... ...

    Abstract The aim of this study was to investigate the association of smoking with disease activity, seropositivity, age and gender in patients with rheumatoid arthritis. We included 89 rheumatoid arthritis patients. All patients fulfilled the 2010 American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis classification criteria. Activity of the disease was measured by Disease Activity Score 28-joint count C-reactive protein (DAS28CRP). The subjects were stratified into smoking and non-smoking groups and cross-sectionally analyzed. There were 24 (27%) smokers and 65 (73%) nonsmokers. The mean age of patients was 57.1±8.8 years. The mean DAS28CRP was 5.81 in the smoking group and 5.57 in the non-smoking group, without statistically significant difference between the two groups (p=0.148). Similarly, smokers did not differ significantly from non-smokers according to age (p=0.443), gender (p=0.274), rheumatoid factor positivity (p=0.231), anti-citrullinated protein antibody positivity (p=0.754) or seropositivity (p=0.163). In this study, we found no association between smoking status and disease activity, seropositivity, age or gender in rheumatoid arthritis patients. Furthermore, disease activity was not related to age, gender or seropositivity. Additional studies on the effects of smoking on rheumatoid arthritis activity are needed.
    MeSH term(s) Aged ; Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/epidemiology ; C-Reactive Protein ; Female ; Humans ; Male ; Middle Aged ; Rheumatoid Factor ; Smoking/adverse effects ; Smoking/epidemiology
    Chemical Substances C-Reactive Protein (9007-41-4) ; Rheumatoid Factor (9009-79-4)
    Language English
    Publishing date 2021-01-12
    Publishing country Croatia
    Document type Journal Article
    ZDB-ID 1478635-7
    ISSN 1333-9451 ; 0353-9466
    ISSN (online) 1333-9451
    ISSN 0353-9466
    DOI 10.20471/acc.2020.59.02.15
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: [ETIOLOGY AND PATHOGENESIS OF PAIN IN RHEUMATIC DISEASES].

    Čulo, Melanie-Ivana / Morović-Vergles, Jadranka

    Reumatizam

    2016  Volume 63 Suppl 1, Page(s) 18–22

    MeSH term(s) Humans ; Pain/etiology ; Rheumatic Diseases/complications ; Rheumatic Diseases/pathology
    Language Croatian
    Publishing date 2016
    Publishing country Croatia
    Document type Journal Article ; Review
    ZDB-ID 604372-0
    ISSN 0374-1338
    ISSN 0374-1338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Patogeneza polimiozitisa i dermatomiozitisa.

    Morović-Vergles, Jadranka / Mitrović, Josko

    Reumatizam

    2012  Volume 59, Issue 2, Page(s) 23–26

    Abstract: The idiopathic inflammatory myopathies, collectively called myositis, are a heterogeneous group of diseases of which polymyositis and dermatomyositis are the best known. These heterogeneous group of chronic disordes sharing the clinical symptom of muscle ...

    Title translation Pathogenesis of polymyositis and dermatomyositis.
    Abstract The idiopathic inflammatory myopathies, collectively called myositis, are a heterogeneous group of diseases of which polymyositis and dermatomyositis are the best known. These heterogeneous group of chronic disordes sharing the clinical symptom of muscle weakness and, in typical cases, inflammatory cell infiltrates in muscle tissue. There are four major types of idiopathic inflammatory myopathies: dermatomyositis, polymyositis, inclusion body myositis and immune-mediated necrotizing myopathies (autoimmune necrotizing myopathies). Clinical and histopatological distinctions between these conditions suggest that different pathogenic processes underline each of the inflammatory myopathies.
    MeSH term(s) Dermatomyositis/immunology ; Dermatomyositis/physiopathology ; Humans ; Polymyositis/immunology ; Polymyositis/physiopathology
    Language Croatian
    Publishing date 2012
    Publishing country Croatia
    Document type English Abstract ; Journal Article
    ZDB-ID 604372-0
    ISSN 0374-1338
    ISSN 0374-1338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top